S&P 500   4,975.51 (-0.60%)
DOW   38,563.80 (-0.17%)
QQQ   427.32 (-0.75%)
AAPL   181.56 (-0.41%)
MSFT   402.79 (-0.31%)
META   471.75 (-0.33%)
GOOGL   141.12 (+0.43%)
AMZN   167.08 (-1.43%)
TSLA   193.76 (-3.10%)
NVDA   694.52 (-4.35%)
NIO   5.96 (-2.93%)
AMD   165.69 (-4.70%)
BABA   73.14 (-1.04%)
T   16.91 (-0.35%)
F   12.25 (-0.41%)
MU   80.71 (+1.52%)
CGC   3.54 (-7.33%)
GE   148.62 (-0.36%)
DIS   109.44 (-1.94%)
AMC   4.66 (-3.52%)
PFE   27.59 (-0.11%)
PYPL   58.63 (-0.86%)
XOM   102.75 (-0.94%)
S&P 500   4,975.51 (-0.60%)
DOW   38,563.80 (-0.17%)
QQQ   427.32 (-0.75%)
AAPL   181.56 (-0.41%)
MSFT   402.79 (-0.31%)
META   471.75 (-0.33%)
GOOGL   141.12 (+0.43%)
AMZN   167.08 (-1.43%)
TSLA   193.76 (-3.10%)
NVDA   694.52 (-4.35%)
NIO   5.96 (-2.93%)
AMD   165.69 (-4.70%)
BABA   73.14 (-1.04%)
T   16.91 (-0.35%)
F   12.25 (-0.41%)
MU   80.71 (+1.52%)
CGC   3.54 (-7.33%)
GE   148.62 (-0.36%)
DIS   109.44 (-1.94%)
AMC   4.66 (-3.52%)
PFE   27.59 (-0.11%)
PYPL   58.63 (-0.86%)
XOM   102.75 (-0.94%)
S&P 500   4,975.51 (-0.60%)
DOW   38,563.80 (-0.17%)
QQQ   427.32 (-0.75%)
AAPL   181.56 (-0.41%)
MSFT   402.79 (-0.31%)
META   471.75 (-0.33%)
GOOGL   141.12 (+0.43%)
AMZN   167.08 (-1.43%)
TSLA   193.76 (-3.10%)
NVDA   694.52 (-4.35%)
NIO   5.96 (-2.93%)
AMD   165.69 (-4.70%)
BABA   73.14 (-1.04%)
T   16.91 (-0.35%)
F   12.25 (-0.41%)
MU   80.71 (+1.52%)
CGC   3.54 (-7.33%)
GE   148.62 (-0.36%)
DIS   109.44 (-1.94%)
AMC   4.66 (-3.52%)
PFE   27.59 (-0.11%)
PYPL   58.63 (-0.86%)
XOM   102.75 (-0.94%)
S&P 500   4,975.51 (-0.60%)
DOW   38,563.80 (-0.17%)
QQQ   427.32 (-0.75%)
AAPL   181.56 (-0.41%)
MSFT   402.79 (-0.31%)
META   471.75 (-0.33%)
GOOGL   141.12 (+0.43%)
AMZN   167.08 (-1.43%)
TSLA   193.76 (-3.10%)
NVDA   694.52 (-4.35%)
NIO   5.96 (-2.93%)
AMD   165.69 (-4.70%)
BABA   73.14 (-1.04%)
T   16.91 (-0.35%)
F   12.25 (-0.41%)
MU   80.71 (+1.52%)
CGC   3.54 (-7.33%)
GE   148.62 (-0.36%)
DIS   109.44 (-1.94%)
AMC   4.66 (-3.52%)
PFE   27.59 (-0.11%)
PYPL   58.63 (-0.86%)
XOM   102.75 (-0.94%)

Ultralife (ULBI) Earnings Date, Estimates & Call Transcripts

$8.82
-0.38 (-4.13%)
(As of 04:00 PM ET)
Skip Charts & View Estimated and Actual Earnings Data

ULBI Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ULBI Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

ULBI Earnings Date and Information

Ultralife has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, April 25th, 2024 based off prior year's report dates.

Ultralife Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
4/25/2024
Estimated)
------- 
10/26/2023Q3 2023-$0.10+$0.10$0.12-$39.49 million
7/27/2023Q2 2023-$0.29+$0.29$0.37-$42.69 million
4/27/2023Q1 2023-($0.02)($0.02)($0.02)-$31.92 million
3/2/2023Q4 2022-$0.04+$0.04$0.09-$36.11 million
10/27/2022Q3 2022-($0.01)($0.01)($0.01)-$33.23 million
7/28/2022Q2 2022-$0.03+$0.03$0.03-$32.13 million
4/28/2022Q1 2022-$0.01+$0.01$0.03-$30.37 million    
2/3/2022Q4 2021-($0.09)($0.09)($0.11)-$23.76 million    
10/28/2021Q3 2021$0.08($0.04)($0.12)($0.06)-$21.76 million    
7/29/2021Q2 2021$0.07$0.05($0.02)$0.07-$26.77 million    
4/29/2021Q1 2021-$0.05+$0.05$0.06-$25.97 million












Ultralife Earnings - Frequently Asked Questions

When is Ultralife's earnings date?

Ultralife has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, April 25th, 2024 based off last year's report dates. Learn more on ULBI's earnings history.

How much revenue does Ultralife generate each year?

Ultralife (NASDAQ:ULBI) has a recorded annual revenue of $158.64 million.

How much profit does Ultralife generate each year?

Ultralife (NASDAQ:ULBI) has a recorded net income of $7.20 million. ULBI has generated $0.44 earnings per share over the last four quarters.

What is Ultralife's price-to-earnings ratio?

Ultralife (NASDAQ:ULBI) has a trailing price-to-earnings ratio of 20.05.


More Earnings Resources from MarketBeat

This page (NASDAQ:ULBI) was last updated on 2/20/2024 by MarketBeat.com Staff